World Vaso-Occlusive Crisis Associated With Sickle Cell Disease Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Overview
  3. Therapeutics Development
  4. Pipeline Products for Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Overview
  5. Pipeline Products for Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Comparative Analysis
  6. Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Therapeutics under Development by Companies
  7. Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Therapeutics under Investigation by Universities/Institutes
  8. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Products under Development by Companies
  13. Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Products under Investigation by Universities/Institutes
  14. Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Companies Involved in Therapeutics Development
  • AstraZeneca Plc
  • Bristol-Myers Squibb Company
  • Complexa, Inc.
  • Dilaforette AB
  • Gilead Sciences, Inc.
  • Mast Therapeutics, Inc.
  • Pfizer Inc.
  • Seattle Genetics, Inc.
  • Selexys Pharmaceuticals Corporation

For more information visit http://www.researchandmarkets.com/research/67g44f/vasoocclusive

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hematological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hematological Drugs